Autologous and allogeneic blood stem cell transplantation: Potential advantage of blood- over marrow-derived stem cell grafts

Cancer Investigation

Volumn 15, Issue 2, 1997, Pages 127-137

  Körbling, Martin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER; HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 1842374403     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709115765     Document Type: Review

References (77)

1. Fliedner TM, Calvo W, Körbling M, Kreutzmann H, Nothdurft W, Ross W, Vassileva D: Hematopoietic stem cells in blood: Characteristics and potentials. In: ICN-UCLA Symposia on Molecular Biology, edited by MJ Cline, D Metcalf, F Fox, 1978, pp 193-212.
2. Fliedner TM, Steinbach KH: Repopulating potential of hematopoietic precursor cells. Blood Cells 14:393-410, 1988.
3. Baum CM, Uchida N, Peault B, Weissman IL: Isolation and characterization of hematopoietic progenitor and stem cells. In: Bone Marrow Transplantation, edited by SJ Foreman, KG Blume, ED Thomas, Blackwell Scientific Publications, 1994, pp 53-71.
4. + cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopathol 70:10-18, 1994.
5. Kukuda T, Okamura S, Shimoda K, Takamatsu Y, Inaba S, Harada M, Niho Y: Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor. Eur J Haematol 52:201-206, 1994.
6. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Eppe DE, Smith DH, Stewart CC, To LB: Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591-1596, 1991.
7. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 84:2795-2801, 1994.
8. To LB, Shepperd KM, Haylock DN, et al: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442-447, 1990.
9. Brugger W, Bross K, Frisch J, et al: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 79:1193-1200, 1992.
10. Sheridan WP, Begley CG, Juttner CA, et al: Effect of peripheral-blood progenitor cells mobilized by filgrastin (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992.
11. Peters W, Rosner G, Ross M, et al: Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709-1719, 1993.
12. Bensinger WI, Price TH, Dale DC, et al: The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 81:1883-1888, 1993.
13. Matsunaga T, Sakamaki S, Kohgo Y, Ohi S, Hirayama Y, Niitsu Y: Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 11:103-108, 1993.
14. Molineux G, Pojda Z, Hampson IN, Lord BI, Dexter TM: Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood 76:2153-2158, 1990.
15. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 82:784-791, 1993.
16. McNiece IK, Briddell RA, Hartley CA, Andrews RG: The role of stem cell factor in mobilization of peripheral blood progenitor cells: Synergy with G-CSF. Stem Cells 11(Suppl 3):83-88, 1993.
17. Andrews RG, Bensinger WI, Knitter GH, et al: The ligand for c-kit, stem cell factor (SCF), stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715-2720, 1992.
18. Hillyer CD, Tiegerman KO, Berkman EM: Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 31:327-332, 1991.
19. Körbling M, Fliedner TM, Pflieger H: Collection of large quantities of granulocyte/macrophage progenitor cells (CFUc) in man by means of continuous-flow leukapheresis. Scand J Haematol 24:22-28, 1980.
20. Malachowski ME, Comenzo RL, Hillyer CD, Tiegerman KO, Berkman EM: Large-volume leukapheresis for peripheral blood stem cell collection in patients with hematologic malignancies. Transfusion 32:732-735, 1992.
21. Comenzo RI, Malachowski ME, Miller KB, et al: Engraftmenl wilh peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 32:729-731, 1992.
22. Passos-Coelho JL, Braine HG, Wright SK et al: Large volume leukapheresis using regional citrate anticoagutation to collect peripheral blood progenitor cells (PBPC). J Hematother (in press).
23. Siena S, Bregni M, Brando B, et al: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 78:400-409, 1991.
24. Shpall EJ, Jones RB, Bearman SI, et al: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 12:28-36, 1994.
25. Moss TJ, Sanders DG, Lasky LC, Bostrom B: Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76:1879-1883, 1990.
26. Moss TJ and Ross AA: The risk of tumor cell contamination in peripheral blood stem cell collections. J Hematother 1:225-232, 1992.
27. Ross AA, Cooper BW, Lazarus HM, Ciobanu N, et al: Immunocytologic detection of tumor cells in peripheral blood stem cell (PBSC) collections of breast cancer patients. Breast Cancer Res Treat 19:171, 1991.
28. Sharp JG, Kessinger A, Vaughan WP, Mann S, et al: Detection and clinical significance of minimal tumor cell contamination of peripheral stem cell harvests. Int J Cell Cloning 10(Suppl 1):92-94, 1992.
29. Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636-640, 1994.
30. Franklin WA, Shpall EJ, Archer P, Johnston CS, Garza-Williams S, Hami L, Bitter MA, Bast RC, Jones RB: Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Cancer 1994 (in press).
31. Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12:475-482, 1994.
32. Hardingham JE, Kotasek D, Sage RE, Dobrovic A, Gooley T, Dale BM : Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 11:15-20, 1993.
33. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma. Hematol Oncol Clin North Am 6:297-322, 1992.
34. Berenson J, Wong R, Kim K, Brown N, Lichtenstein A: Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 70:1550-1553, 1987.
35. Levy Y, Schmitt C, Tsapis A, et al: Phenotype and immunoglobulin gene configuration of blood B cells from patients with multiple myeloma. Clin Exp Immunol 84:435, 1991.
36. Körbling M, Burke P, Braine H, Elfenbein G, Santos G, Kaizer H: Successful engraftment of blood derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol 9:684-690, 1981.
37. Carella AM, Podesla M, Frassoni F, et al: Collection of 'normal' blood repopulating cells during early hematopoietic recovery after intensive conventional chemotherapy inchronic myelogenous leukemia. Bone Marrow Transplant 12:267-271, 1993.
38. Kantarjian HM, Talpaz M, Hester J, Feldman E, Körbling M, Liang J, Rios MB, Calvert L, Deisseroth AB: Collection of peripheral blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive dose chemotherapy (submitted to J Clin Oncol).
39. Gribben JG, Freedman AS, Neuberg D, et al: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525-1533, 1991.
40. Brenner MK, Rill DR, Moen RC, et al: Gene-marking to trace origin of relapse alter autologous bone-marrow transplantation. Lancet 341:85-86, 1993.
41. Palathumpat V, Strang G, Zeitung J, Van Vlasselaer P: Enrichment of committed and uncommitted human hematopoietic progenitor cells using the density gradient based Simplesep enrichment system. Blood, Proc ASH, 1994.
42. Strang G, Palathumpat V, Zeitung J, Hung PL, Van Vlasselaer P: Characterization of natural suppressor cell activity in peripheral blood of G-CSF mobilized healthy volunteers. Blood, Proc ASH, 1994.
43. Negrin RS, Kusnierz-Glaz CR, Still BJ, Schribner JR, Chao NJ, Long GD, Hovle C, Hu WW, Horning SJ, Brown BW, Blume KG, Strober S: Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma (NHL). Blood, Proc ASH, 1994.
44. + cells present in autologous transplants of chronic myelogenous leukemia contribute to relapse after autologous bone marrow in CML. Blood 83:3068-3076, 1994.
45. Verfaillie CM, Miller WJ, Boylan K, et al: Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003-1010, 1992.
46. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B: Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804-2808, 1992.
47. - hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: Implications for gene transduction and/or transplantation. Bone Marrow Transplant 13:649-654, 1994.
48. Moore KA, Deisserolh AB, Reading C, Williams DE, Bemont JW: Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells. Blood 79:1393-1399, 1992.
49. Barnett MJ, Eaves CJ, Phillips GL, et al: Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture. Bone Marrow Transplant 4:345-351, 1989.
50. Palsson BO, Paek SH, Schwartz RM, Palsson M, Lee GM, Silver S, Emerson SG: Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system. Biotechnology 11:368-371, 1993.
51. Emerson SG: Personal communication, 1994.
52. Koller MR, Emerson SG, Palsson BO: Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378-384, 1993.
53. + cells into the myeloid lineage. Blood 80:1405-1412, 1992.
54. + cells. Blood 82:3600-3609, 1993.
55. + progenitor cells by stem cell factor, interleukin-1β (Il-1β), Il-6, 11-3, Interferon-γ, and erythropoietin. Blood 81:2579-2584, 1993.
56. Rill DR, Moen RC, Buschle M, Bartholomew C, Foreman NK, Mirro J Jr, Krance RJ, Ihle JN, Brenner MK: An approach for the analysis of relapse and marrow reconstitution following autologous marrow transplantation using retrovirus mediated gene transfer. Blood 79:2694-2700, 1992.
57. Rill DR, Buschle M, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK: Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene Ther 3:129-136, 1992.
58. Miller AR, Skotzko MJ, Rhoades K, Belldegrun AS, Tso CL, Kaboo R, McBride WH, Jacobs E, Kohn DB, Moen R, Economou JS: Simultaneous use of two retroviral vectors in human gene marking trials: Feasibility and potential applications. Hum Gene Ther 3:619-624, 1992.
59. Hanania EG, Fu S, Zu Z, Hegewisch-Becker S, Korbling M, Andreeff M, Mechetner E, Roninson I, Giles R, Berenson R, Heimfcld S, Deisseroth AB: Chemotherapy resistance to taxol in clonogenic progenitor cells following transduction of CD34 selected marrow and peripheral blood cells with a retrovirus which contains the MDR-1 chemotherapy resistance gene. Gene Ther (in press).
60. Körbling M, Przepiorka D, Engel H, van Besien K, Giralt S, Andersson B, Huh YO, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts. Blood (in press).
61. Schmidt-Wolf IGH, Dejbakhsh-Jones S, Ginzton N, Greenberg P, Strober S: T-cell subsets and suppressor cells in human bone marrow. Blood 80:3242-3250, 1992.
62. Micklem HS, Anderson N, Ross E: Limited potential of circulating haeniopoielic stem cells. Nature 256:41-43, 1975.
63. Körbling M, Dorken B, Ho A, et al: Autdogous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 67:529-532, 1986.
64. Kor̈bling M, Fliedner TM, Holle R et al: Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: Influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 7:343-349, 1991.
65. Laporte JP, Gorin NC, Feuchtenbaum J, Lopez M, Douay L, Lyon-Caen D, Du Puy H, Montbrun MC, Lemonnier MP, Isnard F, Najman A: Relapse after autografting with peripheral blood stem cells. Lancet 2:1393, 1987 (letter).
66. Mehta J, Powles R, Singhal S, Treleaven J: Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplant (in press).
67. Reiffers J: Personal communication, 1994.
68. Dimopoulos MA, Alexanian R, Przepiorka D, Hester J, Andersson B, Giralt S, Mehra R, van Besien K, Delasalle KB, Reading C, Deisseroth AB, Champlin RE: Thiotepa, Busulfan and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 82:2324-2328, 1993.
69. Tepler I, Cannistra SA, Frei III E, Gonin R, Anderson KC, Demetri G, Niloff J, Goodman H, Muntz H, Muto M, Dheets E, Elias AD, Mazanet R, Wheeler C, Ayash L, Schwartz G, McCauley M, Gaynes L, Harvey S, Schnipper LE, Antman KH: Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J Clin Oncol 11:1583-1591, 1993.
70. Kessinger A, Smith DM, Strandjord SE, Landmark JD, Dooley DC, Law P, Coccia PF, Warkentin PI, Weisenburger DD, Armitage JO: Allogeneic transplantation of blood-derived, T-cell depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 4:643-646, 1989.
71. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993 (letter).
72. Matsunaga T, Sakamaki S, Kongo Y, Ohi S, Hirayama Y, Niitsu Y: Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 11:103-108, 1993.
73. Dreger P, Suttorp M, Haferlach T, Loffler H, Schniitz N, Schroyens W: Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404-1407, 1993.
74. Weaver CH, Buckner CD, Longin K, Appelbaum FR, Rowley S, Lilleby K, Miser J, Storb R, Hansen JA, Bensinger W: Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colonystimulating factor. Blood 82:1981-1984, 1993.
75. Nemunaitis J, Albo V, Zeigler ZR, Shadduck RK, Rosenfeld CS: Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells. Leuk Lymphoma 10:405-406, 1993.
76. Engel H, Körbling M, Palmer J, Mehra R, Walker J, Andreeff M, Champlin R: Randomized trial of G-CSF alone vs sequential Interleukin-3 (IL-3) and G-CSF treatment to peripheralize progenitor cells for apheresis and blood stem cell autotransplantation in patients with advanced stage breast cancer. Blood 84(Suppl 1):108a, 1994.
77. Kaushansky K, Lin N, Fox N, Jorgensen M, McCarty J, Lofton-Day C, Zucker-Franklin D, Broudy VC: Thrombopoietin (Tpo), the MPL ligand, is the primary regulator of megakaryocyte (Mk) development and maturation. Blood 84(Suppl 1):241a, 1994.